Descriptor English: | Didanosine | ||||||
Descriptor Spanish: |
Didanosina
| ||||||
Descriptor Portuguese: | Didanosina | ||||||
Descriptor French: | Didéoxyinosine | ||||||
Entry term(s): |
2',3' Dideoxyinosine 2',3'-Dideoxyinosine Dideoxyinosine NSC 612049 NSC-612049 NSC612049 Videx ddI (Antiviral) |
||||||
Tree number(s): |
D03.633.100.759.590.616.130 D13.570.230.500.090 D13.570.583.616.130 D13.570.800.573.130 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D016049 | ||||||
Scope note: | A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antimetabolites Reverse Transcriptase Inhibitors Anti-HIV Agents |
||||||
Registry Number: | K3GDH6OH08 | ||||||
CAS Type 1 Name: | Inosine, 2',3'-dideoxy- | ||||||
Previous Indexing: |
Dideoxynucleosides (1989) Inosine/analogs & derivatives (1987-1989) |
||||||
Public MeSH Note: | 92; was DIDEOXYINOSINE 1990-91 |
||||||
Online Note: | use DIDANOSINE to search DIDEOXYINOSINE 1990-91 |
||||||
History Note: | 92; was DIDEOXYINOSINE 1990-91 |
||||||
DeCS ID: | 30328 | ||||||
Unique ID: | D016049 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1990/01/01 | ||||||
Date of Entry: | 1989/07/14 | ||||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Didanosine
- Preferred
Videx
- Narrower
NSC-612049
- Narrower
Concept UI |
M0024535 |
Scope note | A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. |
Preferred term | Didanosine |
Entry term(s) |
2',3' Dideoxyinosine 2',3'-Dideoxyinosine Dideoxyinosine ddI (Antiviral) |
Concept UI |
M0024536 |
Preferred term | Videx |
Concept UI |
M0328965 |
Preferred term | NSC-612049 |
Entry term(s) |
NSC 612049 NSC612049 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey